期刊文献+

抗菌肽Cec4a的重组表达和抗菌活性研究 被引量:1

Recombinant Expression and Detection of Antimicrobial Activity of Cec4a
原文传递
导出
摘要 目的:构建Cec4a的原核重组表达体系,通过诱导表达、酶切纯化获得重组蛋白,并检测产物的抗菌活性。方法:基于Cec4a的序列设计引物,克隆Cec4a基因的DNA片段。利用原核表达载体(p Cold-SUMO)构建重组原核表达质粒,并将其转化到大肠杆菌C41(DE3)等感受态细胞,使用IPTG进行诱导表达。通过Ni-NTA亲和层析柱纯化,获得含有His-SUMO标签的重组Cec4a融合蛋白。在SUMO蛋白酶酶切后,再次使用Ni-NTA亲和层析纯化,得到目的蛋白,最后用鲍曼不动杆菌(ATCC19606)作为指示菌检测表达产物的抗菌活性。结果:成功构建p Cold-SUMO-Cec4a原核表达质粒,测序分析其序列与预期结果一致。Cec4a融合蛋白表达量为42.8mg/L,纯化后的Cec4a重组蛋白对鲍曼不动杆菌的MIC为4μg/m L。结论:通过原核表达,并经Ni-NTA亲和层析纯化,获得了具有抗菌活性的重组蛋白Cec4a,为研究Cec4a的生物活性、抗菌机制及应用奠定了基础。 Objective:To construct the recombinant expression system of Cec4a,and to obtain the recombinant protein by induced expression and detect the antibacterial activity of the product.Methods:Based on the primers designed according to the sequence of Cec4a,the mature peptide part of Cec4a gene was amplified by PCR.Recombinant prokaryotic expression plasmid was constructed using prokaryotic expression vector(pColdSUMO)and transformed into E.coli C41(DE3)competent cells,which were induced by IPTG.His-SUMO labeled recombinant Cec4a fusion protein was purified by Ni-NTA affinity chromatography.The target protein was purified by Ni-NTA affinity chromatography after SUMO protease digestion.Acinetobacter baumannii(ATCC19606)was used to detect the antibacterial activity of the product.Results:pCold-SUMO-Cec4a prokaryotic expression plasmid was successfully constructed,and the sequencing analysis was consistent with the expected results.The expression level of Cec4a fusion protein was 42.8 mg/L,and the MIC of purified Cec4a recombinant protein against Acinetobacter baumannii was 4μg/m L.Conclusion:The recombinant Cec4a protein with antibacterial activity was successfully constructed and purified by Ni-NTA affinity chromatography.It lays a foundation for further study on the biological activity,the relationship between the structure and function of Cec4a.
作者 陈素芳 夏明印 曾丽艳 安晓琴 田敏芳 彭建 CHEN Su-fang;XIA Ming-yin;ZENG Li-yan;AN Xiao-qin;TIAN Min-fang;PENG Jian(School of Biology and Medical Engineering/Basic Medical College,Guizhou Medical University,Guiyang 550025,China;Key Laboratory of Environmental Pollution and Disease Control of Ministry of Education,Guiyang 550025,China)
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2021年第10期12-18,共7页 China Biotechnology
基金 国家自然科学基金(82002180) 贵州省科技厅科技支撑计划(黔科合支撑[2019]2823号) 贵州省高等学校教学内容和课程体系改革项目(2019046) 大学生创新训练项目(20195200150、20195200931)资助项目。
关键词 Cec4a SUMO 鲍曼不动杆菌 重组表达 Cec4a SUMO Acinetobacter baumannii Recombinant expression
  • 相关文献

参考文献7

二级参考文献70

  • 1丁鹏,王家宁,黄永章,杨波.利用TA克隆载体构建pET15b-SOD1重组质粒[J].郧阳医学院学报,2005,24(2):65-68. 被引量:27
  • 2张雪洋,赵华,胡飞,赵红宇,章锦才.人釉原蛋白编码区基因原核表达载体的构建[J].上海口腔医学,2007,16(1):81-84. 被引量:2
  • 3杨晓明,贺福初,谢玲,胡志远,王清明,邱兆华,吴祖泽.新型人肝再生增强因子的分子克隆及其性能研究[J].新消化病学杂志,1997,5(5):335-335. 被引量:29
  • 4陈长征 黄华 等.大肠杆菌His6融合表达载体及其产物一步纯化[J].Acta Biochinica et Biophysica Sinica(生物化学与生物物理学报:英文版),1996,28:532-530.
  • 5Gutterman JU. Cytokine Therapeutics: lessons from interferon alpha.Proc Natl Acad Sci USA, 1994, 91:1198-1205.
  • 6Nardelli B, Zaritskaya L, Semenuk M, et al. Regulatory effect of IFN-κ, a novel type Ⅰ IFN, on cytokine production by cells of the innate immune system. J Immunol, 2002, 169:4822-4830.
  • 7Lafleur DW, Nardelli B, Tsareva T, et al. Interferon-κ, a novel type Ⅰ interferon expression in human keratinocytes. J Biol Chem, 2001,276: 39765-39771.
  • 8Sharp PM, Li WH. The codon adaptation Index-a measure of directional synonymous codon usage bias, and its potential applications. Nucleic Acids Res, 1987, 15: 1281-1295.
  • 9Brown F, Lubiniecki A, Murano G. Characterization of biotechnology pharmaceutical products. Dev Biol Stand, 1998, 196:97-104.
  • 10Keehyun H, Henry CL,Juan H. Acetic acid formation in escherichia coli fermentation. Biotechnol Bioeng, 1992, 139: 663-671.

共引文献53

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部